Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Sugars × Gynecologic × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Genitourinary 2 Thoracic 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 Classical hematology 1

Conditions

Pain 1 Endometrial Neoplasms 1

Interventions

Paclitaxel 57 Carboplatin 54 Cisplatin 28 pembrolizumab 25 liposomal doxorubicin 20 Cyclophosphamide 20 Topotecan 17 Gemcitabine 16 Bevacizumab 16 Docetaxel 12 niraparib 11 fludarabine 10 Taxes 9 Nivolumab 9 aldesleukin 7 Surveys and Questionnaires 7 Doxorubicin 7 olaparib 6 fludarabine phosphate 6 avelumab 6 Oxaliplatin 6 Interleukin-2 6 Cytoreduction Surgical Procedures 6 rucaparib 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Hyperthermic Intraperitoneal Chemotherapy 5 Fluorodeoxyglucose F18 5 Filgrastim 5 Brachytherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00936598 2014-04-24

Sleep and Endometrial Cancer

University of Pittsburgh

Phase NA Terminated

6 enrolled 5 charts

Pain, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡